Zyvox Injection, Solution
Product Images NDC 66298-5140

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zyvox (NDC 66298-5140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hp Halden Pharma As, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label3

Label for Zyvox 600 mg/300 mL linezolid injection, solution for intravenous use. The label states quantity as 10 IV bags each containing 300 mL. It is indicated as prescription only, with storage instructions to keep at 25°C (77°F) and not to freeze. Distributed by Pharmacia & Upjohn Division of Pfizer Inc., made in Singapore. Contains barcodes and placeholder expiration and lot numbers.*

FDA Label Image

Chemical Structure (Zyvox 01)

Chemical structure of linezolid, the active ingredient in Zyvox 600 mg/300 mL intravenous injection solution by Hp Halden Pharma AS. The structure shows the molecule's ring systems and functional groups as depicted in the image.*

FDA Label Image

Figure 1 (Zyvox 02)

A line graph showing linezolid plasma concentration (µg/mL) over time in hours after a 600 mg oral dose every 12 hours. The graph depicts plasma levels peaking around 1 to 2 hours post-dose and gradually declining until 12 hours.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.